Contact
Please use this form to send email to PR contact of this press release:
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
TO:
Please use this form to send email to PR contact of this press release:
Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
TO: